Lindy Snider - 07 Jun 2021 Form 4 Insider Report for NEXIEN BIOPHARMA, INC. (NXEN)

Role
Director
Signature
Fay Matsukage, by power of attorney
Issuer symbol
NXEN
Transactions as of
07 Jun 2021
Transactions value $
$0
Form type
4
Filing time
07 Jun 2021, 18:00:52 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXEN Common stock Award +250,000 +52% 730,000 07 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NXEN Stock option - right to buy 100,000 07 Jun 2021 Common stock 100,000 $0.54 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued as compensation for service as a director.